Publication Name	World Journal of Gastroenterology
Manuscript ID	6886
Country	Australia

Received	2013-10-29 18:49
Peer-Review Started	2013-10-31 17:47
To Make the First Decision	2014-06-18 17:27
Return for Revision	2014-06-19 08:44
Revised	2014-07-06 17:53
Second Decision	2014-07-30 10:00
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-07-30 10:09
Articles in Press	2014-07-30 10:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-08-09 15:23
Typeset the Manuscript	2014-09-21 15:36
Publish the Manuscript Online	2014-10-16 15:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Adjuvant therapy for gastric cancer: Current and future directions
Manuscript Source	Invited Manuscript
All Author List	Marcus Foo and Trevor Leong
Funding Agency and Grant Number
Corresponding Author	Trevor Leong, Associate Professor, Division of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, St Andrews Place East Melbourne, Victoria 3002, Australia. trevor.leong@petermac.org
Key Words	Adjuvant; Gastric; Stomach; Cancer; Chemoradiation; Chemoradiotherapy; Chemotherapy; Peri-operative; Neo-adjuvant
Core Tip	Surgery remains the cornerstone of curative therapy in gastric cancer. However, a large proportion of patients are diagnosed with locally advanced disease, resulting in poor survival. Randomized trials have now established either post-operative chemoradiotherapy or perioperative chemotherapy as standard adjuvant therapies in the Western world. There remain, however, significant differences in the approach to management between the West and East. In Asia, extended resection followed by adjuvant chemotherapy represents the standard of care. This review discusses the evidence supporting current standard adjuvant therapy in gastric cancer, as well as recent and ongoing trials investigating novel (neo)adjuvant approaches.
Publish Date	2014-10-16 15:53
Citation	Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727
URL	http://www.wjgnet.com/1007-9327/full/v20/i38/13718.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i38.13718

Full Article (PDF)	WJG-20-13718.pdf
Full Article (Word)	WJG-20-13718.doc
Manuscript File	6886-Review.docx
Answering Reviewers	6886-Answering reviewers.pdf
Copyright License Agreement	6886-Copyright assignment.pdf
Peer-review Report	6886-Peer review.pdf
Scientific Misconduct Check	6886-CorssCheck.jpg
Scientific Editor Work List	6886-Scientific editor work list.pdf